Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhenyu Ding

Showing results (101-110 of 118) with videos related to

Pageof 12
Sort By:
Signal Transduction and Targeted Therapy|December 29, 2025
A novel antituberculosis agent exhibits potent clinical efficacy and good safety profile: an open-label, randomized-controlled, multicenter, phase 2a trialNaihui Chu, Wenjuan Nie, Juan Du, et al.
Translational Lung Cancer Research|July 14, 2022
Immune checkpoint inhibitor (ICI)-based treatment beyond progression with prior immunotherapy in patients with stage IV non-small cell lung cancer: a retrospective studyTian Tian, Min Yu, Yang Yu, et al.
International Journal of Clinical Oncology|November 6, 2017
Monitoring the estimated glomerular filtration rate (eGFR) in patients with small-cell lung cancer during chemotherapy: equations based on serum creatinine or cystatin C?Xue Tian, Xinxing Zhang, Min Yu, et al.
Lung Cancer (Amsterdam, Netherlands)|May 3, 2016
Impact of whole brain radiation therapy on CSF penetration ability of Icotinib in EGFR-mutated non-small cell lung cancer patients with brain metastases: Results of phase I dose-escalation studyLin Zhou, Jiazhuo He, Weijie Xiong, et al.
Journal of Thoracic Disease|April 3, 2018
Assessment of programmed cell death ligand-1 expression with multiple immunohistochemistry antibody clones in non-small cell lung cancerChen Pang, Limei Yin, Xiaojuan Zhou, et al.
Medicine|April 29, 2016
Adjuvant Therapeutic Modalities in Primary Small Cell Carcinoma of Esophagus Patients: A Retrospective Cohort Study of Multicenter Clinical OutcomesBingwen Zou, Tao Li, Qiang Zhou, et al.
Oncotarget|January 18, 2018
Concurrent brain radiotherapy and EGFR-TKI may improve intracranial metastases control in non-small cell lung cancer and have survival benefit in patients with low DS-GPA scoreYongmei Liu, Lei Deng, Xiaojuan Zhou, et al.
Oncotarget|June 8, 2017
Efficacy of epidermal growth factor receptor-tyrosine kinase inhibitors for lung squamous carcinomas harboring EGFR mutation: A multicenter study and pooled analysis of published reportsYongmei Liu, Yan Zhang, Li Zhang, et al.
International Journal of Environmental Research and Public Health|February 25, 2023
Design and Implementation of a Chain-Type Direct Push Drilling Rig for Contaminated SitesPinghe Sun, Shengwei Zhou, Han Cao, et al.
Oncology Letters|March 21, 2018
Comparison of chemotherapy plus bevacizumab vs. chemotherapy alone as third-line treatment or beyond for advanced non-small cell lung cancer: A propensity score-matched analysisBinbin Hu, Xiaojuan Zhou, Yongmei Liu, et al.
Pageof 12

Showing results (101-110 of 118) with videos related to

Sort By:
Pageof 12
Signal Transduction and Targeted Therapy|December 29, 2025
A novel antituberculosis agent exhibits potent clinical efficacy and good safety profile: an open-label, randomized-controlled, multicenter, phase 2a trialNaihui Chu, Wenjuan Nie, Juan Du, et al.
Translational Lung Cancer Research|July 14, 2022
Immune checkpoint inhibitor (ICI)-based treatment beyond progression with prior immunotherapy in patients with stage IV non-small cell lung cancer: a retrospective studyTian Tian, Min Yu, Yang Yu, et al.
International Journal of Clinical Oncology|November 6, 2017
Monitoring the estimated glomerular filtration rate (eGFR) in patients with small-cell lung cancer during chemotherapy: equations based on serum creatinine or cystatin C?Xue Tian, Xinxing Zhang, Min Yu, et al.
Lung Cancer (Amsterdam, Netherlands)|May 3, 2016
Impact of whole brain radiation therapy on CSF penetration ability of Icotinib in EGFR-mutated non-small cell lung cancer patients with brain metastases: Results of phase I dose-escalation studyLin Zhou, Jiazhuo He, Weijie Xiong, et al.
Journal of Thoracic Disease|April 3, 2018
Assessment of programmed cell death ligand-1 expression with multiple immunohistochemistry antibody clones in non-small cell lung cancerChen Pang, Limei Yin, Xiaojuan Zhou, et al.
Medicine|April 29, 2016
Adjuvant Therapeutic Modalities in Primary Small Cell Carcinoma of Esophagus Patients: A Retrospective Cohort Study of Multicenter Clinical OutcomesBingwen Zou, Tao Li, Qiang Zhou, et al.
Oncotarget|January 18, 2018
Concurrent brain radiotherapy and EGFR-TKI may improve intracranial metastases control in non-small cell lung cancer and have survival benefit in patients with low DS-GPA scoreYongmei Liu, Lei Deng, Xiaojuan Zhou, et al.
Oncotarget|June 8, 2017
Efficacy of epidermal growth factor receptor-tyrosine kinase inhibitors for lung squamous carcinomas harboring EGFR mutation: A multicenter study and pooled analysis of published reportsYongmei Liu, Yan Zhang, Li Zhang, et al.
International Journal of Environmental Research and Public Health|February 25, 2023
Design and Implementation of a Chain-Type Direct Push Drilling Rig for Contaminated SitesPinghe Sun, Shengwei Zhou, Han Cao, et al.
Oncology Letters|March 21, 2018
Comparison of chemotherapy plus bevacizumab vs. chemotherapy alone as third-line treatment or beyond for advanced non-small cell lung cancer: A propensity score-matched analysisBinbin Hu, Xiaojuan Zhou, Yongmei Liu, et al.
Pageof 12